ES8304091A1 - Procedimiento para preparar derivados de imidazol. - Google Patents

Procedimiento para preparar derivados de imidazol.

Info

Publication number
ES8304091A1
ES8304091A1 ES511317A ES511317A ES8304091A1 ES 8304091 A1 ES8304091 A1 ES 8304091A1 ES 511317 A ES511317 A ES 511317A ES 511317 A ES511317 A ES 511317A ES 8304091 A1 ES8304091 A1 ES 8304091A1
Authority
ES
Spain
Prior art keywords
lower alkyl
substituted
same
different
represent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES511317A
Other languages
English (en)
Other versions
ES511317A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of ES511317A0 publication Critical patent/ES511317A0/es
Publication of ES8304091A1 publication Critical patent/ES8304091A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR DERIVADOS DE IMIDAZOL. SE HACE REACCIONAR EL COMPUESTO (II) DONDE EL ANILLO IMIDAZOL PUEDE ESTAR SUSTITUIDO CON UNO O MAS SUSTITUYENTES ALQUILO INFERIOR, CON EL COMPUESTO Q ALK AR SIENDO Q UN GRUPO DESPLAZABLE NUCLEOFILO. SE OBTIENE EL COMPUESTO (I) QUE OPCIONALMENTE PUEDE AISLARSE COMO UNA SAL DE ADICION DE ACIDO FARMACEUTICAMENTE ACEPTABLE Y SI ES NECESARIO, SE SOMETE A HIDROLISIS CON UNA BASE PARA TRANSFORMAR LOS SUSTITUYENTES CARBOXIALQUILO EN SUSTITUYENTES CARBOXI. LA REACCION PUEDE EFECTUARSE A TEMPERATURAS COMPRENDIDAS ENTRE 15 C Y 20 C O ESTEN DEL ORDEN DE 75 C.
ES511317A 1981-04-13 1982-04-08 Procedimiento para preparar derivados de imidazol. Expired ES8304091A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8111614 1981-04-13

Publications (2)

Publication Number Publication Date
ES511317A0 ES511317A0 (es) 1983-02-16
ES8304091A1 true ES8304091A1 (es) 1983-02-16

Family

ID=10521121

Family Applications (1)

Application Number Title Priority Date Filing Date
ES511317A Expired ES8304091A1 (es) 1981-04-13 1982-04-08 Procedimiento para preparar derivados de imidazol.

Country Status (12)

Country Link
US (2) US4567189A (es)
EP (1) EP0062918B1 (es)
JP (1) JPS57179165A (es)
CA (1) CA1174680A (es)
DE (1) DE3272262D1 (es)
DK (1) DK162882A (es)
ES (1) ES8304091A1 (es)
IE (1) IE52702B1 (es)
NO (1) NO157736C (es)
NZ (1) NZ200300A (es)
PT (1) PT74736B (es)
ZA (1) ZA822478B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3369984D1 (en) * 1982-07-12 1987-04-09 Searle & Co 1-(1h-imidazolyl), 1-n-morpholinyl and pyridyl compounds, their preparation and pharmaceutical compositions containing them
FR2557875B1 (fr) * 1984-01-11 1986-04-25 Jouveinal Sa Aminoethylimidazole, composition pharmaceutique en contenant et procede de preparation
GB8712694D0 (en) * 1987-05-29 1987-07-01 Scras Tetrahydrofurans etc
US5214063A (en) * 1990-06-27 1993-05-25 Adir Et Compagnie 4-aminobutyric acid compounds, compositions and methods of use for treating disorders related to a dysfunction of GABAB receptors
GB9127304D0 (en) * 1991-12-23 1992-02-19 Boots Co Plc Therapeutic agents
GB9312893D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
US5747523A (en) * 1996-01-24 1998-05-05 Guilford Pharmaceuticals Inc. Substituted ethyl α,α-diarylmethyl ether derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036970A (en) * 1975-07-28 1977-07-19 Syntex (U.S.A.) Inc. Imidazol-1-yl propane derivatives
DE2720949A1 (de) * 1977-05-10 1978-11-23 Bayer Ag Azolylaether-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide
US4215220A (en) * 1978-09-11 1980-07-29 Cilag-Chemie A.G. 1-(2-Oxysubstituted-3-anilinopropyl)-imidazoles
DK157860C (da) * 1979-06-07 1990-07-30 Shionogi & Co Analogifremgangsmaade til fremstilling af benzylimidazolderivater samt farmaceutisk acceptable syreadditionssalte deraf

Also Published As

Publication number Publication date
IE820868L (en) 1982-10-13
JPS57179165A (en) 1982-11-04
ZA822478B (en) 1983-02-23
DK162882A (da) 1982-10-14
JPH0368864B2 (es) 1991-10-30
NZ200300A (en) 1985-05-31
EP0062918B1 (en) 1986-07-30
ES511317A0 (es) 1983-02-16
NO157736B (no) 1988-02-01
NO821206L (no) 1982-10-14
EP0062918A2 (en) 1982-10-20
PT74736B (en) 1983-11-09
NO157736C (no) 1988-05-11
CA1174680A (en) 1984-09-18
US4567189A (en) 1986-01-28
EP0062918A3 (en) 1983-09-28
DE3272262D1 (en) 1986-09-04
US4636518A (en) 1987-01-13
PT74736A (en) 1982-05-01
IE52702B1 (en) 1988-01-20

Similar Documents

Publication Publication Date Title
ES8704926A1 (es) Un procedimiento para la preparacion de derivados de benzotiazol y benzotiofeno
ATE2322T1 (de) Substituierte imidazole, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ES8401042A1 (es) Un procedimiento para la preparacion de nuevos derivados de triazina.
GB2110663B (en) Imidazole derivatives
DK492283A (da) Fremgangsmaade til fremstilling af naphthalenderivater
ES8304091A1 (es) Procedimiento para preparar derivados de imidazol.
NO159794C (no) Analogifremgangsm te ved fremstilling av terapeutisk virksomme 7-substituerte theofyllinderivater.
JPS5750989A (en) Imidazole compound
ES8601201A1 (es) Procedimiento para preparar derivados de imidazolina
EP0268990A3 (en) New benzothiadiazine compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
ES8205770A1 (es) Procedimiento para la preparacion de derivados de 2,3-indo- lediona
ES8604219A1 (es) Un procedimiento para la preparacion de benzoquinolicinas
EP0098609A3 (en) Novel cephalosporin compounds
ES8306111A1 (es) "un procedimiento para la preparacion de una quinolona".
AU558461B2 (en) Carbamyloxybenzhyrol derivatives
ES8506641A1 (es) Procedimiento para preparar 1-acetonil-2-(fenilimino)-imidazolidinas
IE811212L (en) Substituted phenoxy-aminopropanol derivatives
ES8305758A1 (es) "un procedimiento para la preparacion de 2-(1,4-benzodioxan-2-il-metil)-imidazolina".
GR79151B (es)
ES8403130A1 (es) Procedimiento para la preparacion de tienobenzodiazepinonas sustituidas.
ES8502694A1 (es) Procedimiento para preparar 1,3,4-benzotriazepinas sustituidas.
ES2010471A6 (es) Procedimiento de preparar nuevos derivados de los acidos 1,4-dihidro-4-oxoquinolein-3-carboxilicos.
ATE30675T1 (de) Benzobicyclononanamin-derivate mit antikonvulsiven eigenschaften.
ES8301991A1 (es) Procedimiento para la preparacion de 7-(2,6-dibromo-4-metil-fenil)-2,3-dihidro-imidazo 1,2-a, imidazoles.